• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中的脑脊液tau蛋白、神经颗粒素和神经丝轻链蛋白

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

作者信息

Mattsson Niklas, Insel Philip S, Palmqvist Sebastian, Portelius Erik, Zetterberg Henrik, Weiner Michael, Blennow Kaj, Hansson Oskar

机构信息

Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden Department of Neurology, Skåne University Hospital, Lund, Sweden

Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden Department of Radiology, University of California San Francisco, San Francisco, CA, USA.

出版信息

EMBO Mol Med. 2016 Oct 4;8(10):1184-1196. doi: 10.15252/emmm.201606540. Print 2016 Oct.

DOI:10.15252/emmm.201606540
PMID:27534871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5048367/
Abstract

Cerebrospinal fluid (CSF) tau (total tau, T-tau), neurofilament light (NFL), and neurogranin (Ng) are potential biomarkers for neurodegeneration in Alzheimer's disease (AD). It is unknown whether these biomarkers provide similar or complementary information in AD. We examined 93 patients with AD, 187 patients with mild cognitive impairment, and 109 controls. T-tau, Ng, and NFL were all predictors of AD diagnosis. Combinations improved the diagnostic accuracy (AUC 85.5% for T-tau, Ng, and NFL) compared to individual biomarkers (T-tau 80.8%; Ng 71.4%; NFL 77.7%). T-tau and Ng were highly correlated (ρ = 0.79, P < 0.001) and strongly associated with β-amyloid (Aβ) pathology, and with longitudinal deterioration in cognition and brain structure, primarily in people with Aβ pathology. NFL on the other hand was not associated with Aβ pathology and was associated with cognitive decline and brain atrophy independent of Aβ. T-tau, Ng, and NFL provide partly independent information about neuronal injury and may be combined to improve the diagnostic accuracy for AD. T-tau and Ng reflect Aβ-dependent neurodegeneration, while NFL reflects neurodegeneration independently of Aβ pathology.

摘要

脑脊液(CSF)中的总tau蛋白(T-tau)、神经丝轻链(NFL)和神经颗粒素(Ng)是阿尔茨海默病(AD)神经退行性变的潜在生物标志物。目前尚不清楚这些生物标志物在AD中提供的是相似信息还是互补信息。我们对93例AD患者、187例轻度认知障碍患者和109名对照者进行了研究。T-tau、Ng和NFL均为AD诊断的预测指标。与单个生物标志物相比,联合使用可提高诊断准确性(T-tau、Ng和NFL联合的曲线下面积为85.5%,T-tau为80.8%;Ng为71.4%;NFL为77.7%)。T-tau和Ng高度相关(ρ = 0.79,P < 0.001),并与β-淀粉样蛋白(Aβ)病理改变以及认知和脑结构的纵向恶化密切相关,主要见于有Aβ病理改变的人群。另一方面,NFL与Aβ病理改变无关,且与认知衰退和脑萎缩相关,独立于Aβ。T-tau、Ng和NFL提供了关于神经元损伤的部分独立信息,可联合使用以提高AD的诊断准确性。T-tau和Ng反映Aβ依赖性神经退行性变,而NFL反映独立于Aβ病理改变的神经退行性变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/86d387bcc500/EMMM-8-1184-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/c63b7d183b62/EMMM-8-1184-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/dfb4df96491c/EMMM-8-1184-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/a034b3cc8d4d/EMMM-8-1184-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/f5e30d574e7f/EMMM-8-1184-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/b5a5b93f7b93/EMMM-8-1184-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/86d387bcc500/EMMM-8-1184-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/c63b7d183b62/EMMM-8-1184-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/dfb4df96491c/EMMM-8-1184-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/a034b3cc8d4d/EMMM-8-1184-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/f5e30d574e7f/EMMM-8-1184-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/b5a5b93f7b93/EMMM-8-1184-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4adb/5048367/86d387bcc500/EMMM-8-1184-g005.jpg

相似文献

1
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.阿尔茨海默病中的脑脊液tau蛋白、神经颗粒素和神经丝轻链蛋白
EMBO Mol Med. 2016 Oct 4;8(10):1184-1196. doi: 10.15252/emmm.201606540. Print 2016 Oct.
2
Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease.阿尔茨海默病中脑脊液和血浆神经退行性变生物标志物与脑萎缩之间的关联
Neurobiol Aging. 2017 Oct;58:14-29. doi: 10.1016/j.neurobiolaging.2017.06.002. Epub 2017 Jun 17.
3
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.神经退行性变、突触完整性和星形胶质细胞激活的脑脊液生物标志物在整个临床阿尔茨海默病谱中。
Alzheimers Dement. 2019 May;15(5):644-654. doi: 10.1016/j.jalz.2019.01.004. Epub 2019 Mar 8.
4
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.阿尔茨海默病患者纵向血浆神经丝轻链与神经退行性变的关系。
JAMA Neurol. 2019 Jul 1;76(7):791-799. doi: 10.1001/jamaneurol.2019.0765.
5
Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.比较 CSF 神经丝轻链、神经颗粒素和 tau 与 MRI 标志物。
Alzheimers Dement. 2021 May;17(5):801-812. doi: 10.1002/alz.12239. Epub 2021 Mar 4.
6
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.特发性正常压力脑积水神经退行性生物标志物的脑脊液时间趋势。
J Alzheimers Dis. 2021;80(4):1629-1642. doi: 10.3233/JAD-201361.
7
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.非β-淀粉样蛋白/tau 脑脊液标志物可提示阿尔茨海默病的分期和进展。
Alzheimers Res Ther. 2018 Sep 25;10(1):98. doi: 10.1186/s13195-018-0426-3.
8
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.阿尔茨海默病患者血浆神经丝轻链与神经退行性变的关联
JAMA Neurol. 2017 May 1;74(5):557-566. doi: 10.1001/jamaneurol.2016.6117.
9
Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology.脑脊液神经退行性变生物标志物与阿尔茨海默病和血管病理学标志物的相关性。
J Alzheimers Dis. 2023;92(3):887-898. doi: 10.3233/JAD-221015.
10
Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.70 岁老年人脑脊液神经丝轻链和神经颗粒素升高认知的细微差异:一项 H70 横断面研究。
J Alzheimers Dis. 2023;91(1):291-303. doi: 10.3233/JAD-220452.

引用本文的文献

1
CSF total tau as a proxy of synaptic degeneration.脑脊液总tau蛋白作为突触退化的替代指标。
Nat Commun. 2025 Aug 29;16(1):8076. doi: 10.1038/s41467-025-63545-5.
2
From Amyloid to Synaptic Dysfunction: Biomarker-Driven Insights into Alzheimer's Disease.从淀粉样蛋白到突触功能障碍:基于生物标志物的阿尔茨海默病见解
Curr Issues Mol Biol. 2025 Jul 22;47(8):580. doi: 10.3390/cimb47080580.
3
Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer's disease in a population-based sample of 70-year-olds.在一个基于70岁人群样本中,饮酒与临床前阿尔茨海默病的脑脊液生物标志物研究

本文引用的文献

1
Revolutionizing Alzheimer's disease and clinical trials through biomarkers.通过生物标志物革新阿尔茨海默病及临床试验。
Alzheimers Dement (Amst). 2015 Oct 3;1(4):412-9. doi: 10.1016/j.dadm.2015.09.001. eCollection 2015 Dec.
2
Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology.与β-淀粉样蛋白病理学相关的认知衰退加速率及影像标志物。
Neurology. 2016 May 17;86(20):1887-96. doi: 10.1212/WNL.0000000000002683. Epub 2016 Apr 15.
3
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
Alzheimers Res Ther. 2025 Jul 25;17(1):175. doi: 10.1186/s13195-025-01819-2.
4
Multimorbidity patterns and blood biomarkers of Alzheimer's disease in community-dwelling cognitively unimpaired older adults.社区居住的认知未受损老年人中阿尔茨海默病的共病模式和血液生物标志物
Alzheimers Dement. 2025 Jun;21(6):e70411. doi: 10.1002/alz.70411.
5
Regional Brain Metabolism across the Alzheimer's Disease Continuum in Down Syndrome.唐氏综合征患者阿尔茨海默病连续病程中的区域脑代谢
Ann Neurol. 2025 Jul;98(1):163-173. doi: 10.1002/ana.27226. Epub 2025 Mar 14.
6
Development of Neurodegenerative Disease Diagnosis and Monitoring from Traditional to Digital Biomarkers.从传统生物标志物到数字生物标志物的神经退行性疾病诊断与监测的发展
Biosensors (Basel). 2025 Feb 11;15(2):102. doi: 10.3390/bios15020102.
7
Plasma N-terminal tau fragment is an amyloid-dependent biomarker in Alzheimer's disease.血浆N端tau片段是阿尔茨海默病中一种依赖淀粉样蛋白的生物标志物。
Alzheimers Dement. 2025 Mar;21(3):e14550. doi: 10.1002/alz.14550. Epub 2025 Jan 17.
8
The Diagnostic Value of Cerebrospinal Fluid Neurogranin in Neurodegenerative Diseases.脑脊液神经颗粒素在神经退行性疾病中的诊断价值
Int J Mol Sci. 2024 Dec 19;25(24):13578. doi: 10.3390/ijms252413578.
9
Understanding recent advances in non-amyloid/non-tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease.了解阿尔茨海默病中非淀粉样蛋白/非tau蛋白(NANT)生物标志物和治疗靶点的最新进展。
Alzheimers Dement (N Y). 2024 Nov 22;10(4):e70014. doi: 10.1002/trc2.70014. eCollection 2024 Oct-Dec.
10
Plasma markers of neurodegeneration, latent cognitive abilities and physical activity in healthy aging.健康老龄化中神经退行性变、潜在认知能力和身体活动的血浆标志物。
Sci Rep. 2024 Sep 17;14(1):21702. doi: 10.1038/s41598-024-72806-0.
神经颗粒素在阿尔茨海默病中的诊断和预后价值。
JAMA Neurol. 2016 May 1;73(5):561-71. doi: 10.1001/jamaneurol.2016.0086.
4
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.临床前阿尔茨海默病:定义、自然史及诊断标准。
Alzheimers Dement. 2016 Mar;12(3):292-323. doi: 10.1016/j.jalz.2016.02.002.
5
Increased CSF neurogranin concentration is specific to Alzheimer disease.脑脊液中神经颗粒素浓度升高是阿尔茨海默病所特有的。
Neurology. 2016 Mar 1;86(9):829-35. doi: 10.1212/WNL.0000000000002423. Epub 2016 Jan 29.
6
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.脑脊液神经颗粒蛋白和 YKL-40 作为阿尔茨海默病的生物标志物。
Ann Clin Transl Neurol. 2015 Nov 20;3(1):12-20. doi: 10.1002/acn3.266. eCollection 2016 Jan.
7
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease.神经颗粒素和YKL-40:阿尔茨海默病中突触退化和神经炎症的独立标志物。
Alzheimers Res Ther. 2015 Dec 24;7:74. doi: 10.1186/s13195-015-0161-y.
8
Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repair.脑脊液中的总tau蛋白和神经丝轻链反映了血管内主动脉修复术后的脊髓缺血。
Neurochem Int. 2016 Feb;93:1-5. doi: 10.1016/j.neuint.2015.12.003. Epub 2015 Dec 10.
9
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.脑脊液神经丝轻链浓度与阿尔茨海默病进展的关联
JAMA Neurol. 2016 Jan;73(1):60-7. doi: 10.1001/jamaneurol.2015.3037.
10
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.脑脊液神经颗粒蛋白:与阿尔茨海默病认知及神经退行性变的关系
Brain. 2015 Nov;138(Pt 11):3373-85. doi: 10.1093/brain/awv267. Epub 2015 Sep 15.